This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Economics Remove Hurdle Rate Remove Pharmaceutical Related Topics
IFRS GAAP Restructuring Corporate Finance Valuation Communication Securities Numbers Investments Accounting More Related Topics >
article thumbnail

Musings on Markets: Data Update 5 for 2022: The Bottom Line!

CFO News Room

JANUARY 18, 2023

The last few years have been eventful for all companies, with the COVID crisis and ensuing economic shut down causing pain for companies, with recovery coming in 2021, as the global economy opened up again. Costs grow at a slower rate than revenues. Superior unit economics. Economies of scale. High gross margins.

Marketing 130
Marketing Hurdle Rate Investments Accounting 130
article thumbnail

Data Update 5 for 2022: The Bottom Line!

Musings on Markets

FEBRUARY 27, 2022

The last few years have been eventful for all companies, with the COVID crisis and ensuing economic shut down causing pain for companies, with recovery coming in 2021, as the global economy opened up again. I will use this data to draw three broad conclusions: Low Hurdle Rate ?

Hurdle Rate 80
Hurdle Rate Investments Accounting Entertainment 80
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 68,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
LinkedIn Twitter
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024